Hemolytic uremic syndrome following the infusion of oxaliplatin: case report

BACKGROUND: Oxaliplatin is a platinum derivative, which is used in the treatment of colorectal cancer. A small number of oxaliplatin-related hemolytic and/or thrombocytopenic reactions have been reported. We present a case of hemolytic-uremic syndrome that developed during the 4(th )cycle of combina...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahabreh, Issa, Tsoutsos, George, Tseligas, Dimitrios, Janinis, Dimitrios
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574347/
https://www.ncbi.nlm.nih.gov/pubmed/16968538
http://dx.doi.org/10.1186/1472-6904-6-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574347/
https://www.ncbi.nlm.nih.gov/pubmed/16968538
http://dx.doi.org/10.1186/1472-6904-6-5

Ejemplares similares